Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC729430 Inhibitors

LOC729430 inhibitor compounds such as Staurosporine, a kinase inhibitor, can suppress various kinases within the cellular milieu, potentially affecting phosphorylation events that regulate LOC729430's activity or its interaction with other proteins. Similarly, Thapsigargin raises intracellular calcium levels, which could disrupt calcium-dependent signaling mechanisms that LOC729430 may be a part of. Antimetabolites like 5-Fluorouracil interfere with nucleotide synthesis, which could result in altered expression levels of LOC729430 due to changes in RNA synthesis or DNA replication. Epigenetic modifiers such as Trichostatin A, which inhibits histone deacetylases, can alter gene expression profiles, potentially affecting the transcription of the LOC729430 gene. Cyclosporin A, by inhibiting calcineurin, might alter phosphatase activity, impacting signaling networks that involve LOC729430. Compounds that affect cellular structure or division, such as Paclitaxel, could disrupt processes in which LOC729430 plays a part, given its involvement in cell cycle regulation.

Glycosylation inhibitors like Tunicamycin may affect the folding and function of glycoproteins, which could include LOC729430 if it undergoes glycosylation. Proteasome inhibitors, for example, MG132, can prevent the degradation of proteins, potentially leading to an accumulation of LOC729430, altering its cellular concentration and activity. Inhibitors of signaling pathways, such as LY290042, which targets PI3K, could disrupt downstream pathways, impacting LOC729430's associated processes. Additionally, metabolic pathway inhibitors like 2-Deoxy-D-glucose can alter energy metabolism, potentially affecting the energy-dependent functions of LOC729430. Compounds with broad signaling modulation effects, such as Curcumin, can influence multiple pathways, thus altering the cellular context of LOC729430. Simvastatin impacts cholesterol biosynthesis, which could influence membrane composition and signaling pathways wherein LOC729430 may participate.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can suppress a broad spectrum of kinases which could be upstream or downstream of LOC729430.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

A SERCA pump inhibitor that elevates cytosolic calcium levels, potentially affecting calcium-dependent processes involving LOC729430.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

An antimetabolite that can disrupt nucleotide synthesis, potentially affecting the expression or function of LOC729430.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that can change chromatin structure and gene expression, possibly influencing LOC729430 expression.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that inhibits calcineurin, potentially altering signaling pathways involving LOC729430.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

A microtubule stabilizer that can disrupt cell division and signaling pathways, possibly affecting LOC729430's role in the cell.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

An N-linked glycosylation inhibitor that can disrupt protein folding and potentially affect the function of glycoproteins like LOC729430 if applicable.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that prevents protein degradation, which could stabilize LOC729430 and affect its function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can disrupt various signaling pathways, potentially impacting processes associated with LOC729430.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

A glycolysis inhibitor that can alter energy metabolism, potentially affecting the function or expression of LOC729430.